Literature DB >> 1991276

Imaging bone tumors in the 1990s.

W A Murphy1.   

Abstract

Progress in bone tumor management has occurred as a result of cooperation among surgeons, oncologists, pathologists, and radiologists. During the 1990s radiologists will contribute to care of patients with bone tumors in major ways. Tumor detection and preliminary diagnosis will be accomplished by radiography. Tumor local extent will be assessed by magnetic resonance imaging (MRI) and to a lesser degree by computed tomography (CT). Distant spread of malignancy will be documented by radionuclide scintigraphy (skeleton) and by CT (lungs). The combined estimate of local extent and distant spread will assure adequate staging before definitive management decisions. Preoperative closed percutaneous biopsy for histologic diagnosis will be accomplished on an outpatient basis under fluoroscopic or CT guidance. Arteriography will be employed for delivery of local chemotherapy. Some combination of arteriography, MRI, and MR spectroscopy will be used to evaluate tumor response. After limb-salvage surgery, MRI will sequentially assess the tumor bed; bone scintigraphy and CT will detect skeletal and pulmonary metastases. The radiologist's role will undergo continuous redefinition.

Entities:  

Mesh:

Year:  1991        PMID: 1991276     DOI: 10.1002/1097-0142(19910215)67:4+<1169::aid-cncr2820671511>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.

Authors:  Timm Denecke; Patrick Hundsdörfer; Daniel Misch; Ingo G Steffen; Stefan Schönberger; Christian Furth; Michail Plotkin; Juri Ruf; Hubertus Hautzel; Brigitte Stöver; Regine Kluge; Uta Bierbach; Sylke Otto; James F Beck; Christiane Franzius; Günter Henze; Holger Amthauer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05-27       Impact factor: 9.236

2.  Vena cava filters.

Authors:  J N King; A M Champlin; R N Ashby
Journal:  West J Med       Date:  1992-03

3.  Magnetic resonance imaging of musculoskeletal tumors.

Authors:  R D Boutin; M R Williamson
Journal:  West J Med       Date:  1992-03

4.  Comparison of plain radiographs and magnetic resonance images in the evaluation of periosteal reaction and osteoid matrix in osteosarcomas.

Authors:  R Dosdá; L Martí-Bonmatí; F Menor; F Aparisi; C Rodrigo; V Ricart
Journal:  MAGMA       Date:  1999-10       Impact factor: 2.310

Review 5.  Percutaneous bone biopsy, techniques and indications.

Authors:  W Berning; J Freyschmidt; H Ostertag
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

6.  Carbon-11-methionine positron emission tomography imaging of chordoma.

Authors:  Hong Zhang; Kyosan Yoshikawa; Katsumi Tamura; Kenji Sagou; Mei Tian; Tetsuya Suhara; Susumu Kandatsu; Kazutoshi Suzuki; Shuji Tanada; Hirohiko Tsujii
Journal:  Skeletal Radiol       Date:  2004-07-28       Impact factor: 2.199

7.  [F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults.

Authors:  Douglas S Hawkins; Ernest U Conrad; James E Butrynski; Scott M Schuetze; Janet F Eary
Journal:  Cancer       Date:  2009-08-01       Impact factor: 6.860

8.  Relationships between plain-film radiographic patterns and clinicopathologic variables in AJCC stage II osteosarcoma.

Authors:  Min Suk Kim; Soo-Yong Lee; Wan Hyeong Cho; Won Seok Song; Jae-Soo Koh; Jun Ah Lee; Ji Young Yoo; Sung Taek Jung; Dae-Geun Jeon
Journal:  Skeletal Radiol       Date:  2008-07-12       Impact factor: 2.199

Review 9.  The role of SPET and PET in monitoring tumour response to therapy.

Authors:  Chariklia Giannopoulou
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-14       Impact factor: 9.236

Review 10.  Consolidation of massive bone allografts in limb-preserving operations for bone tumours.

Authors:  M San Julian Aranguren; M Leyes; G Mora; J Cañadell
Journal:  Int Orthop       Date:  1995       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.